Reply to A. Grothey et al and R.S. Midgley et al

Comment

Robert J Mayer. J Clin Oncol. 2013.

. 2013 Apr 20;31(12):1612-3.

doi: 10.1200/JCO.2012.47.8859.

No abstract available

Comment on

Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought.
Mayer RJ. Mayer RJ. J Clin Oncol. 2012 Sep 20;30(27):3325-7. doi: 10.1200/JCO.2012.44.1949. Epub 2012 Aug 20. J Clin Oncol. 2012. PMID: 22915653 No abstract available.
Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
Midgley RS, Kerr DJ. Midgley RS, et al. J Clin Oncol. 2013 Apr 20;31(12):1611. doi: 10.1200/JCO.2012.47.2852. Epub 2013 Mar 18. J Clin Oncol. 2013. PMID: 23509312 No abstract available.
Disease-free survival in colon cancer: still relevant after all these years!
Grothey A, de Gramont A, Sargent DJ. Grothey A, et al. J Clin Oncol. 2013 Apr 20;31(12):1609-10. doi: 10.1200/JCO.2012.47.4452. Epub 2013 Mar 18. J Clin Oncol. 2013. PMID: 23509315 No abstract available.